S Oberbeck,A Schrader,K Warner,D Jungherz,G Crispatzu,J von Jan,M Chmielewski,A Ianevski,H H Diebner,P Mayer,A Kondo Ados,L Wahnschaffe,T Braun,T A Müller,P Wagle,A Bouska,T Neumann,S Pützer,L Varghese,N Pflug,M Thelen,J Makalowski,N Riet,H J M Göx,G Rappl,J Altmüller,M Kotrová,T Persigehl,G Hopfinger,M L Hansmann,H Schlößer,S Stilgenbauer,J Dürig,D Mougiakakos,M von Bergwelt-Baildon,I Roeder,S Hartmann,M Hallek,R Moriggl,M Brüggemann,T Aittokallio,J Iqbal,S Newrzela,H Abken,M Herling

Abstract:T-cell prolymphocytic leukemia (T-PLL) is a poor-prognostic neoplasm. Differentiation stage and immune-effector functions of the underlying tumor cell are insufficiently characterized. Constitutive activation of the T-cell leukemia 1A (TCL1A) oncogene distinguishes the (pre)leukemic cell from regular postthymic T cells. We assessed activation-response patterns of the T-PLL lymphocyte and interrogated the modulatory impact by TCL1A. Immunophenotypic and gene expression profiles revealed a unique spectrum of memory-type differentiation of T-PLL with predominant central-memory stages and frequent noncanonical patterns. Virtually all T-PLL expressed a T-cell receptor (TCR) and/or CD28-coreceptor without overrepresentation of specific TCR clonotypes. The highly activated leukemic cells also revealed losses of negative-regulatory TCR coreceptors (eg, CTLA4). TCR stimulation of T-PLL cells evoked higher-than-normal cell-cycle transition and profiles of cytokine release that resembled those of normal memory T cells. More activated phenotypes and higher TCL1A correlated with inferior clinical outcomes. TCL1A was linked to the marked resistance of T-PLL to activation- and FAS-induced cell death. Enforced TCL1A enhanced phospho-activation of TCR kinases, second-messenger generation, and JAK/STAT or NFAT transcriptional responses. This reduced the input thresholds for IL-2 secretion in a sensitizer-like fashion. Mice of TCL1A-initiated protracted T-PLL development resembled such features. When equipped with epitope-defined TCRs or chimeric antigen receptors, these Lckpr-hTCL1Atg T cells gained a leukemogenic growth advantage in scenarios of receptor stimulation. Overall, we propose a model of T-PLL pathogenesis in which TCL1A enhances TCR signals and drives the accumulation of death-resistant memory-type cells that use amplified low-level stimulatory input, and whose loss of negative coregulators additionally maintains their activated state. Treatment rationales are provided by combined interception in TCR and survival signaling.

Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family–negative T-prolymphocytic leukemia

T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment

TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy

Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene

Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia

Comparison of karyotyping, TCL1 fluorescence in situ hybridisation and TCL1 immunohistochemistry in T cell prolymphocytic leukaemia

T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement

Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia

High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia

TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients

Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling

T-cell prolymphocytic leukemia: a single-institution experience

From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature

Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia

Does a subset of mature T-cell leukemias with features akin to T-cell prolymphocytic leukemia but lacking rearrangement of the TCL1 represent peripheral T-cell lymphoma, NOS in a leukemic phase?

Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact

T-PLL Presenting with an Indolent Course

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

[TCL1-family negative T-cell prolymphocytic leukemia with rapid progression of extranodal disease despite a normal white blood cell count]

A Novel JAK2 Fusion in T‐Cell Prolymphocytic Leukemia